Perrigo Company plc $PRGO Shares Purchased by State of Alaska Department of Revenue

State of Alaska Department of Revenue grew its position in shares of Perrigo Company plc (NYSE:PRGO) by 695.7% during the 3rd quarter, Holdings Channel reports. The firm owned 122,855 shares of the company’s stock after purchasing an additional 107,416 shares during the period. State of Alaska Department of Revenue’s holdings in Perrigo were worth $2,735,000 at the end of the most recent reporting period.

Several other large investors also recently made changes to their positions in PRGO. SG Americas Securities LLC bought a new stake in shares of Perrigo in the 3rd quarter worth approximately $188,000. VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new position in Perrigo in the third quarter worth approximately $234,000. Slocum Gordon & Co LLP increased its holdings in shares of Perrigo by 1.1% in the third quarter. Slocum Gordon & Co LLP now owns 53,253 shares of the company’s stock valued at $1,186,000 after buying an additional 602 shares in the last quarter. West Tower Group LLC lifted its position in shares of Perrigo by 45.7% during the 3rd quarter. West Tower Group LLC now owns 173,241 shares of the company’s stock valued at $3,858,000 after acquiring an additional 54,327 shares during the last quarter. Finally, Blue Trust Inc. boosted its stake in shares of Perrigo by 42.2% during the 3rd quarter. Blue Trust Inc. now owns 5,036 shares of the company’s stock worth $112,000 after acquiring an additional 1,494 shares in the last quarter. Institutional investors own 95.91% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have recently issued reports on PRGO shares. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Perrigo in a research report on Monday, December 22nd. Jefferies Financial Group dropped their price target on Perrigo from $27.00 to $23.00 and set a “hold” rating on the stock in a research note on Monday, October 27th. Wall Street Zen lowered shares of Perrigo from a “buy” rating to a “hold” rating in a research note on Saturday, November 8th. JPMorgan Chase & Co. lowered their price objective on shares of Perrigo from $20.00 to $18.00 and set a “neutral” rating on the stock in a research report on Monday, December 15th. Finally, Zacks Research lowered Perrigo from a “hold” rating to a “strong sell” rating in a report on Friday, November 7th. One equities research analyst has rated the stock with a Buy rating, two have issued a Hold rating and two have issued a Sell rating to the company. Based on data from MarketBeat.com, Perrigo has an average rating of “Reduce” and a consensus target price of $20.33.

Insider Activity

In related news, Director Geoffrey M. Parker acquired 7,500 shares of the firm’s stock in a transaction on Wednesday, November 12th. The shares were purchased at an average price of $14.18 per share, with a total value of $106,350.00. Following the acquisition, the director directly owned 17,375 shares in the company, valued at $246,377.50. The trade was a 75.95% increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this link. 0.40% of the stock is owned by corporate insiders.

Perrigo Price Performance

Shares of NYSE:PRGO opened at $15.05 on Wednesday. The company has a debt-to-equity ratio of 0.81, a current ratio of 2.51 and a quick ratio of 1.44. The business has a 50-day moving average of $13.75 and a two-hundred day moving average of $20.20. The stock has a market capitalization of $2.07 billion, a P/E ratio of -39.61 and a beta of 0.40. Perrigo Company plc has a fifty-two week low of $12.17 and a fifty-two week high of $30.93.

Perrigo (NYSE:PRGO) last announced its earnings results on Wednesday, November 5th. The company reported $0.80 earnings per share for the quarter, beating the consensus estimate of $0.75 by $0.05. The firm had revenue of $1.04 billion during the quarter, compared to the consensus estimate of $1.10 billion. Perrigo had a positive return on equity of 9.16% and a negative net margin of 1.21%.The firm’s revenue for the quarter was down 4.1% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.81 EPS. Perrigo has set its FY 2025 guidance at 2.700-2.80 EPS. On average, equities research analysts predict that Perrigo Company plc will post 2.56 EPS for the current fiscal year.

Perrigo Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, December 16th. Investors of record on Friday, November 28th were issued a dividend of $0.29 per share. This represents a $1.16 dividend on an annualized basis and a yield of 7.7%. The ex-dividend date of this dividend was Friday, November 28th. Perrigo’s dividend payout ratio (DPR) is currently -305.26%.

About Perrigo

Perrigo Company plc is a global healthcare supplier specializing in over-the-counter (OTC) and self-care products, as well as generic prescription pharmaceuticals and active pharmaceutical ingredients. The company develops, manufactures and distributes a broad array of consumer health products, including analgesics, vitamins and supplements, digestive health remedies, topical treatments, and infant formulas. Perrigo’s focus on private-label solutions has made it a leading partner for retailers and pharmacy chains seeking high-quality, value-oriented alternatives to branded medications and health supplements.

Organized across three principal business segments—Consumer Healthcare, Prescription Pharmaceuticals and Active Pharmaceutical Ingredients—Perrigo’s operations span research and development, manufacturing, quality assurance and global distribution.